The abstract is read at the publisher; the summary is JClub's.
In children aged 6–12 years with high myopia, nightly 0.10% atropine slowed 24-month cycloplegic spherical equivalent progression to -0.56 D, versus -0.92 D with 0.01%.
- Why it matters: High myopia in children can lead to irreversible visual impairment, but the best atropine concentration for controlling progression and balancing safety remains uncertain.
- What they did: In a multicenter double-blind randomized trial in Shanghai, 219 children with myopia ≤ -5.0 D received nightly 0.01% (N=76), 0.04% (N=72), or 0.10% (N=71) atropine eyedrops for 24 months; cycloplegic SE change from baseline was measured.
- The result: After 24 months, 0.10% reduced myopia progression by 0.35 D (95%CI: 0.12 D, 0.58 D) versus 0.01%, while 0.04% was not significantly different; photophobia was most frequent at 24 months (7.8%, 8.1%, 21.1%).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.